Skip to main content

Table 4 Meta-analysis for lymph node metastasis

From: Prognostic prediction of systemic immune-inflammation index for patients with gynecological and breast cancers: a meta-analysis

Comparison Studies RR (95%CI) PA value I2 PH value Model
Overall   7 1.34(1.20, 1.50) < 0.001 0.0 0.544 F
Subgroup  
Country Asian 7 1.34(1.20, 1.50) < 0.001 0.0 0.544 F
Non-Asian 0
Sample size < 200 3 1.30(1.05, 1.61) 0.017 0.0 0.707 F
> 200 4 1.36(1.19, 1.55) < 0.001 27.3 0.248 F
Cut-off < 600 4 1.18(0.97, 1.43) 0.094 0.0 0.393 F
> 600 3 1.46(1.27, 1.67) < 0.001 0.0 0.972 F
Cancer type Cervical cancer 2 1.04(0.74, 1.48) 0.807 0.0 0.338 F
Ovarian cancer 2 1.47(1.23, 1.75) < 0.001 0.0 0.881 F
Breast cancer 3 1.35(1.15, 1.59) < 0.001 0.0 0.617 F
TNBC 1 1.43(1.13, 1.80) 0.0003
Other BC type 2 1.29(1.03, 1.60) 0.026 0.0 0.404 F
Follow-up < 48 m 5 1.31(1.13, 1.52) < 0.001 16.4 0.310 F
> 48 m 2 1.41(1.19, 1.66) < 0.001 0.0 0.822 F
  1. TNBC triple-negative breast cancer, RR relative risk, CI confidence interval, m month, F fixed-effects, PAP value for association, PHP value for heterogeneity